When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IMGN - ImmunoGen up 27% premarket on accelerated pathway for mirvetuximab soravtansine
ImmunoGen Inc.
ImmunoGen (NASDAQ:IMGN) announces that the FDA has advised that a new single-arm study in platinum-resistant ovarian cancer could support accelerated approval for mirvetuximab soravtansine.
More news on: ImmunoGen, Inc., Healthcare stocks news, Stocks on the move,